News

Medica 2023

CPO Iain Hendrick and Software QA Manager Steven George attended Medica 2023 in Düsseldorf, Germany to showcase the newly FDA cleared Modius Sleep headset.

November 24, 2023 — Craig McConnell

Meet The Team - Steven George - Software QA Manager

I'm Steven George, but most people know me as Stevie. I've been at Neurovalens almost 6 years, it feels like no time since I joined yet so much has changed and so much has been achieved.

November 22, 2023 — Craig McConnell

Neurovalens receives FDA clearance for medical device to treat insomnia

Neurovalens, a global leader in non-invasive neuro-technology, has received medical device clearance from the US Food & Drug Administration (FDA) to treat chronic insomnia with its Modius Sleep device.

October 31, 2023 — Craig McConnell

Meet The Team - Erin McCulloch - Clinical Trial Coordinator

My name is Erin, and I am a Clinical Trial Coordinator at Neurovalens. I joined the team in September 2020. I initially joined Neurovalens as a year-long placement student during my Pharmaceutical Biotechnology at Queen’s University Belfast.

October 17, 2023 — Craig McConnell

Modius Spero - A non-invasive, drug-free technology being trialled as a potential treatment for PTSD

Neurovalens is studying the efficacy of a non-invasive electrical vestibular nerve stimulation (VeNS) device, the Modius Spero device, as a method of treating Post-Traumatic Stress Disorder (PTSD).

March 10, 2023 — Aidan Flanagan

Meet The Team - Iain Hendrick - CPO

Iain Hendrick is Chief Project Officer at Neurovalens. He studied Electrical & Electronic Engineering, focused on Control Systems & DSP. Enjoys working at Neurovalens for its impactful technology and great team, hobbies include cycling and playing guitar.

February 08, 2023 — Aidan Flanagan

Meet The Team - Chris McCabe - CTO

In this Q&A session with our CTO, Chris McCabe, we delve into his background and journey in the tech industry. He shares how he got into the field and what led him to join Neurovalens. Chris also shares his thoughts on what he enjoys about his work plus much more.

January 13, 2023 — Aidan Flanagan

World Diabetes Day

Diabetes is a chronic disease, that causes blood sugar levels in your body to become too high, either due to your body not being able to respond properly to insulin or due to your body not being unable to produce any at all. If left untreated, this can lead to serious complications such as heart attack, stroke, obesity, eye disease, kidney disease and nerve damage.

November 18, 2022 — Aidan Flanagan

Make Mental Health a Priority

There are nearly one billion people worldwide who suffer from mental disorders. There is a stigma surrounding mental health making it difficult to speak up and seek help.

Covid 19 has been a huge impact on people's mental health all around the world. Within the first year of Covid-19, there has been a 25% increase in anxiety and depression worldwide.

October 28, 2022 — Aidan Flanagan

How Sleep Deprivation Can Lead to Weight Gain

Sleep is an important factor to help maintain health and well-being. It’s recommended that an adult should get at least 7 hours of sleep a night. Getting a good night’s sleep has many benefits such as better memory, reduced stress levels and lowers the risk of heart disease.

October 28, 2022 — Aidan Flanagan

The Sunday Times | Sir Richard Branson & co pick their start-ups of 2019

These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education.

January 21, 2022 — Chris Miskelly

The Irish News | Latest cash injection sees medical tech firm Neurovalens target US growth

A BELFAST technology firm developing a number of specialised medical devices has received its second major cash injection in a month.
Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.